[Predictive tests of response to radiotherapy. Assessment and perspectives in 1997].
The potential tailoring of radiotherapy modalities to the biological characteristics of individual tumours and normal tissues appears to be an exciting way to improve the therapeutic, ratio in radiation therapy patients. Numerous assays have been proposed to provide the clinician with the biological information necessary to predict the outcome after irradiation and to guide the treatment prescription, but none of them has made its way to daily practice. Major difficulties are due to the technical burden of the procedures, the poor characterization of the assayed cells, and, moreover, the high complexity of tumour and normal tissues biology. The present paper reviews the present status of the assessment of tumour cells radiosensitivity, proliferation and oxygenation. Research remains extremely active in the field of biological predictors of response to irradiation. Future steps forwards are expected from progress in the available technologies, (re-)discovery of apoptosis and investigation of normal tissue tolerance.
Dubray
B
B
Département d'oncologie-radiothérapie, institut Curie, Paris, France.
Pavy
J J
JJ
Giraud
P
P
Danhier
S
S
Cosset
J M
JM
D017209:Apoptosis; D002455:Cell Division / Q000528:radiation effects*; D004307:Dose-Response Relationship, Radiation; D005434:Flow Cytometry; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy; D011237:Predictive Value of Tests; D011878:Radiotherapy / Q000639:trends; D014407:Tumor Cells, Cultured / Q000528:radiation effects
Les tests prédictifs de la réponse à la radiothérapie: bilan et perspectives en 1997.